Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hodgkin Disease | 14 | 2022 | 1377 | 1.120 |
Why?
|
Lymphoma, Non-Hodgkin | 9 | 2019 | 1373 | 0.860 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 10 | 2024 | 1402 | 0.810 |
Why?
|
Vincristine | 8 | 2024 | 1038 | 0.770 |
Why?
|
Central Nervous System Neoplasms | 7 | 2023 | 916 | 0.710 |
Why?
|
Lymphoma, Follicular | 5 | 2017 | 453 | 0.660 |
Why?
|
Electronic Mail | 1 | 2020 | 213 | 0.640 |
Why?
|
Vidarabine | 5 | 2024 | 336 | 0.630 |
Why?
|
Lymphoma | 7 | 2023 | 1896 | 0.610 |
Why?
|
Cyclophosphamide | 13 | 2024 | 2218 | 0.610 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 8 | 2024 | 1627 | 0.600 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 23 | 2024 | 11709 | 0.590 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2020 | 329 | 0.590 |
Why?
|
Lymphoma, B-Cell | 5 | 2017 | 935 | 0.460 |
Why?
|
Documentation | 1 | 2020 | 892 | 0.460 |
Why?
|
Neoplasm Staging | 14 | 2020 | 11152 | 0.450 |
Why?
|
Doxorubicin | 8 | 2024 | 2209 | 0.430 |
Why?
|
Arabinonucleosides | 1 | 2013 | 34 | 0.430 |
Why?
|
Neurotoxicity Syndromes | 3 | 2023 | 300 | 0.430 |
Why?
|
Adenine Nucleotides | 1 | 2013 | 111 | 0.420 |
Why?
|
Machado-Joseph Disease | 1 | 2012 | 26 | 0.400 |
Why?
|
Prednisone | 7 | 2024 | 1565 | 0.380 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2023 | 675 | 0.380 |
Why?
|
Electronic Health Records | 3 | 2020 | 4761 | 0.370 |
Why?
|
Medical Oncology | 6 | 2022 | 2312 | 0.360 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2023 | 5649 | 0.360 |
Why?
|
Methotrexate | 6 | 2015 | 1719 | 0.350 |
Why?
|
Anthracyclines | 3 | 2023 | 282 | 0.340 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 167 | 0.340 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 638 | 0.320 |
Why?
|
Immunotherapy, Adoptive | 4 | 2024 | 1454 | 0.320 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 7 | 2014 | 693 | 0.300 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 623 | 0.300 |
Why?
|
Breast Implants | 1 | 2011 | 409 | 0.290 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 586 | 0.290 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2006 | 16 | 0.270 |
Why?
|
Patient Care | 1 | 2012 | 622 | 0.270 |
Why?
|
Transplantation Conditioning | 6 | 2014 | 1588 | 0.260 |
Why?
|
Neoplasms | 12 | 2022 | 22032 | 0.260 |
Why?
|
Bleomycin | 1 | 2007 | 495 | 0.260 |
Why?
|
Erythema | 1 | 2007 | 262 | 0.250 |
Why?
|
Neutropenia | 4 | 2019 | 884 | 0.250 |
Why?
|
Transplantation Chimera | 5 | 2004 | 595 | 0.250 |
Why?
|
Remission Induction | 8 | 2019 | 2388 | 0.250 |
Why?
|
Middle Aged | 68 | 2024 | 219568 | 0.240 |
Why?
|
Waldenstrom Macroglobulinemia | 5 | 2014 | 1067 | 0.240 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2006 | 178 | 0.240 |
Why?
|
Stem Cell Transplantation | 5 | 2018 | 1599 | 0.220 |
Why?
|
Hospitalization | 8 | 2020 | 10652 | 0.220 |
Why?
|
Adenine | 3 | 2024 | 975 | 0.210 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2023 | 237 | 0.210 |
Why?
|
Disease-Free Survival | 13 | 2018 | 6821 | 0.210 |
Why?
|
Recurrence | 11 | 2018 | 8426 | 0.200 |
Why?
|
Positron-Emission Tomography | 6 | 2016 | 6457 | 0.200 |
Why?
|
Humans | 113 | 2024 | 758406 | 0.200 |
Why?
|
Piperidines | 4 | 2024 | 1639 | 0.200 |
Why?
|
Pyrimidines | 6 | 2021 | 3006 | 0.200 |
Why?
|
Leukopoiesis | 1 | 2001 | 55 | 0.190 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 111 | 0.190 |
Why?
|
Busulfan | 5 | 2017 | 258 | 0.190 |
Why?
|
Antigens, CD19 | 1 | 2024 | 424 | 0.190 |
Why?
|
Fund Raising | 1 | 2021 | 49 | 0.190 |
Why?
|
Male | 75 | 2024 | 358747 | 0.190 |
Why?
|
Bone Marrow Transplantation | 5 | 2003 | 2693 | 0.180 |
Why?
|
Gene Rearrangement | 3 | 2017 | 1122 | 0.180 |
Why?
|
Aged | 49 | 2024 | 168218 | 0.180 |
Why?
|
Oncogenes | 2 | 2017 | 1220 | 0.180 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 3 | 2009 | 263 | 0.180 |
Why?
|
Graft vs Host Disease | 10 | 2018 | 3024 | 0.180 |
Why?
|
Female | 70 | 2024 | 390323 | 0.180 |
Why?
|
Adult | 55 | 2024 | 219935 | 0.180 |
Why?
|
Drug Hypersensitivity | 2 | 2021 | 915 | 0.170 |
Why?
|
Data Mining | 2 | 2015 | 551 | 0.170 |
Why?
|
Symporters | 1 | 2022 | 360 | 0.170 |
Why?
|
Capillaries | 2 | 2019 | 744 | 0.160 |
Why?
|
Lymphocyte Depletion | 5 | 2004 | 602 | 0.160 |
Why?
|
Microscopy, Video | 1 | 2019 | 242 | 0.160 |
Why?
|
Transplantation, Autologous | 7 | 2023 | 2114 | 0.160 |
Why?
|
Burkitt Lymphoma | 2 | 2011 | 333 | 0.150 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2004 | 685 | 0.150 |
Why?
|
Vinblastine | 1 | 2019 | 487 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 249 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 839 | 0.140 |
Why?
|
Treatment Outcome | 24 | 2024 | 64378 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 6 | 2018 | 20500 | 0.130 |
Why?
|
Dacarbazine | 1 | 2019 | 559 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3175 | 0.130 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4839 | 0.130 |
Why?
|
Stomach Neoplasms | 1 | 2006 | 1422 | 0.130 |
Why?
|
Biopsy | 5 | 2017 | 6768 | 0.130 |
Why?
|
Hydronephrosis | 1 | 2017 | 271 | 0.130 |
Why?
|
Natural Language Processing | 2 | 2015 | 1134 | 0.130 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 352 | 0.130 |
Why?
|
Massachusetts | 5 | 2020 | 8823 | 0.130 |
Why?
|
Transplantation, Homologous | 10 | 2018 | 4809 | 0.130 |
Why?
|
Combined Modality Therapy | 7 | 2017 | 8530 | 0.130 |
Why?
|
Resuscitation Orders | 1 | 2017 | 270 | 0.120 |
Why?
|
Central Nervous System | 2 | 2023 | 1333 | 0.120 |
Why?
|
H-Y Antigen | 2 | 2004 | 42 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1404 | 0.120 |
Why?
|
Palliative Care | 3 | 2020 | 3570 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8506 | 0.120 |
Why?
|
Prognosis | 14 | 2020 | 29557 | 0.120 |
Why?
|
Lichen Planus, Oral | 1 | 2014 | 56 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2018 | 1593 | 0.110 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 40 | 0.110 |
Why?
|
Telemedicine | 2 | 2023 | 3018 | 0.110 |
Why?
|
Hematopoiesis | 2 | 2002 | 2047 | 0.110 |
Why?
|
Aged, 80 and over | 18 | 2019 | 58683 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4580 | 0.110 |
Why?
|
Tacrolimus | 3 | 2015 | 733 | 0.110 |
Why?
|
Back Pain | 1 | 2017 | 543 | 0.110 |
Why?
|
Edema | 1 | 2017 | 768 | 0.110 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 124 | 0.110 |
Why?
|
Sarcopenia | 1 | 2018 | 372 | 0.110 |
Why?
|
Retrospective Studies | 20 | 2024 | 80168 | 0.100 |
Why?
|
Receptors, Notch | 1 | 2017 | 743 | 0.100 |
Why?
|
Lymphocyte Transfusion | 3 | 2002 | 232 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 137 | 0.100 |
Why?
|
Jaundice | 1 | 2013 | 97 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 714 | 0.100 |
Why?
|
Pyrazoles | 2 | 2021 | 1988 | 0.100 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 155 | 0.100 |
Why?
|
Sirolimus | 4 | 2015 | 1533 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 2 | 2017 | 1356 | 0.100 |
Why?
|
Cerebrospinal Fluid | 1 | 2015 | 544 | 0.100 |
Why?
|
Leg | 1 | 2017 | 1087 | 0.100 |
Why?
|
Administration, Oral | 3 | 2019 | 3991 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1432 | 0.100 |
Why?
|
Silicone Gels | 1 | 2011 | 39 | 0.100 |
Why?
|
Mouth Mucosa | 1 | 2014 | 426 | 0.100 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2011 | 13 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 565 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 304 | 0.090 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12951 | 0.090 |
Why?
|
Thiotepa | 3 | 2017 | 66 | 0.090 |
Why?
|
Pelvic Bones | 1 | 1993 | 270 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39059 | 0.090 |
Why?
|
Hospice Care | 1 | 2017 | 677 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21017 | 0.090 |
Why?
|
Mediastinal Neoplasms | 1 | 2013 | 402 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2782 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2014 | 708 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 927 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 91 | 0.090 |
Why?
|
Pilot Projects | 2 | 2020 | 8553 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 375 | 0.090 |
Why?
|
Microfluidics | 1 | 2015 | 652 | 0.080 |
Why?
|
Length of Stay | 3 | 2018 | 6439 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2011 | 15637 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10171 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 989 | 0.080 |
Why?
|
Injections, Intravenous | 2 | 2010 | 1378 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1477 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13245 | 0.080 |
Why?
|
Anaphylaxis | 1 | 2016 | 755 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2020 | 1829 | 0.080 |
Why?
|
Immunosuppressive Agents | 3 | 2009 | 4158 | 0.080 |
Why?
|
Myeloablative Agonists | 1 | 2009 | 209 | 0.080 |
Why?
|
Immunoconjugates | 1 | 2016 | 949 | 0.080 |
Why?
|
Body Composition | 1 | 2018 | 2416 | 0.080 |
Why?
|
Ki-67 Antigen | 2 | 2012 | 631 | 0.080 |
Why?
|
Hematologic Diseases | 2 | 2019 | 496 | 0.080 |
Why?
|
Interleukin-2 | 3 | 2004 | 1888 | 0.080 |
Why?
|
Patient Readmission | 2 | 2020 | 3261 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2014 | 702 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2006 | 15773 | 0.070 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3858 | 0.070 |
Why?
|
Lung | 1 | 2006 | 9985 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2017 | 3485 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4738 | 0.070 |
Why?
|
Disease Progression | 5 | 2012 | 13468 | 0.070 |
Why?
|
Ascitic Fluid | 1 | 2007 | 189 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1893 | 0.070 |
Why?
|
Urinary Bladder | 1 | 1993 | 1166 | 0.070 |
Why?
|
Optic Nerve Diseases | 1 | 2010 | 342 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 1993 | 793 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3733 | 0.070 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13591 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2016 | 2004 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2889 | 0.070 |
Why?
|
Immunophenotyping | 4 | 2016 | 1871 | 0.070 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1198 | 0.070 |
Why?
|
Exotoxins | 2 | 1997 | 121 | 0.070 |
Why?
|
Herpesviridae Infections | 1 | 2007 | 270 | 0.060 |
Why?
|
Cause of Death | 2 | 2017 | 3675 | 0.060 |
Why?
|
Herpesvirus 8, Human | 1 | 2007 | 255 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2004 | 4549 | 0.060 |
Why?
|
Pericardial Effusion | 1 | 2007 | 247 | 0.060 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 520 | 0.060 |
Why?
|
Patient Discharge | 1 | 2017 | 3433 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2012 | 9273 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2004 | 431 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5629 | 0.060 |
Why?
|
Pleural Effusion | 1 | 2007 | 342 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 659 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2012 | 10416 | 0.060 |
Why?
|
Thiazoles | 1 | 2011 | 1510 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2017 | 5272 | 0.060 |
Why?
|
Diphtheria Toxin | 1 | 2004 | 252 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15399 | 0.050 |
Why?
|
Isoantibodies | 2 | 2004 | 661 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15785 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2635 | 0.050 |
Why?
|
Mastectomy | 1 | 2011 | 1832 | 0.050 |
Why?
|
Celiac Disease | 1 | 2011 | 822 | 0.050 |
Why?
|
Piperazines | 2 | 2004 | 2511 | 0.050 |
Why?
|
Risk | 2 | 2016 | 9599 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2015 | 3806 | 0.050 |
Why?
|
Mutation | 3 | 2019 | 29915 | 0.050 |
Why?
|
Echocardiography | 1 | 2015 | 4962 | 0.050 |
Why?
|
Young Adult | 11 | 2020 | 58808 | 0.050 |
Why?
|
Neoplasms, Second Primary | 1 | 2010 | 1056 | 0.050 |
Why?
|
Breast | 1 | 2011 | 1963 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2014 | 5249 | 0.050 |
Why?
|
Methods | 1 | 2002 | 1074 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2014 | 2504 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5246 | 0.050 |
Why?
|
Gene Frequency | 2 | 2013 | 3612 | 0.050 |
Why?
|
Perceptual Masking | 1 | 1982 | 90 | 0.050 |
Why?
|
Heart Failure | 2 | 2023 | 11593 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2013 | 2325 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4282 | 0.050 |
Why?
|
Gastrectomy | 1 | 2006 | 670 | 0.050 |
Why?
|
Fractures, Bone | 1 | 1993 | 2040 | 0.050 |
Why?
|
Cytarabine | 2 | 2014 | 696 | 0.050 |
Why?
|
Adolescent | 10 | 2020 | 87892 | 0.050 |
Why?
|
Surge Capacity | 1 | 2020 | 48 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4464 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4560 | 0.040 |
Why?
|
Radiography | 2 | 2006 | 6954 | 0.040 |
Why?
|
Censuses | 1 | 2021 | 201 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 15225 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14641 | 0.040 |
Why?
|
Fatigue | 2 | 2020 | 1542 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12262 | 0.040 |
Why?
|
Rheumatic Diseases | 1 | 2006 | 639 | 0.040 |
Why?
|
Survival Analysis | 4 | 2019 | 10112 | 0.040 |
Why?
|
Inpatients | 2 | 2021 | 2551 | 0.040 |
Why?
|
Cohort Studies | 7 | 2019 | 41256 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8057 | 0.040 |
Why?
|
Psychometrics | 2 | 2019 | 3052 | 0.040 |
Why?
|
Dyspnea | 1 | 2006 | 1344 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12075 | 0.040 |
Why?
|
Salvage Therapy | 3 | 2011 | 1268 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6493 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2008 | 1647 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 850 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3774 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6172 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3714 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2007 | 1780 | 0.040 |
Why?
|
Home Infusion Therapy | 1 | 2016 | 18 | 0.030 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.030 |
Why?
|
Cell Lineage | 2 | 2003 | 2533 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9160 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1007 | 0.030 |
Why?
|
Survival Rate | 4 | 2015 | 12721 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2002 | 960 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2019 | 649 | 0.030 |
Why?
|
Prospective Studies | 5 | 2022 | 54137 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10504 | 0.030 |
Why?
|
Stroke Volume | 2 | 2023 | 5460 | 0.030 |
Why?
|
Incidence | 4 | 2018 | 21272 | 0.030 |
Why?
|
Psychological Tests | 1 | 2018 | 639 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1997 | 562 | 0.030 |
Why?
|
Desensitization, Immunologic | 1 | 2021 | 534 | 0.030 |
Why?
|
Treatment Failure | 2 | 2013 | 2640 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2018 | 481 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2002 | 4353 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2002 | 1765 | 0.030 |
Why?
|
United States | 4 | 2021 | 72136 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 371 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5331 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2016 | 356 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2015 | 191 | 0.030 |
Why?
|
ADP Ribose Transferases | 1 | 1995 | 90 | 0.030 |
Why?
|
Immunotoxins | 1 | 1995 | 175 | 0.030 |
Why?
|
p300-CBP Transcription Factors | 1 | 2015 | 150 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3617 | 0.030 |
Why?
|
Hospices | 1 | 2017 | 245 | 0.030 |
Why?
|
World Health Organization | 2 | 2011 | 1312 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2015 | 315 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23342 | 0.030 |
Why?
|
Gene Duplication | 1 | 2015 | 313 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 391 | 0.030 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 105 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2002 | 22029 | 0.030 |
Why?
|
Unified Medical Language System | 1 | 2014 | 89 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2017 | 11471 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2015 | 452 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.030 |
Why?
|
Visual Perception | 1 | 1982 | 1374 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2021 | 1192 | 0.030 |
Why?
|
Microcirculation | 1 | 2018 | 1273 | 0.030 |
Why?
|
Endocytosis | 1 | 1997 | 958 | 0.030 |
Why?
|
Narration | 1 | 2015 | 219 | 0.030 |
Why?
|
Periodicity | 1 | 2014 | 348 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1060 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 540 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.030 |
Why?
|
Hepatorenal Syndrome | 1 | 2013 | 76 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1931 | 0.030 |
Why?
|
Electroretinography | 1 | 2014 | 517 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3812 | 0.020 |
Why?
|
Sulfonamides | 1 | 2021 | 1973 | 0.020 |
Why?
|
Rupture | 1 | 1993 | 443 | 0.020 |
Why?
|
Exanthema | 1 | 2016 | 504 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4711 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8611 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1141 | 0.020 |
Why?
|
Virulence Factors | 1 | 1995 | 511 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1185 | 0.020 |
Why?
|
Eye | 1 | 1995 | 710 | 0.020 |
Why?
|
Aspergillus fumigatus | 1 | 1992 | 156 | 0.020 |
Why?
|
Secondary Prevention | 2 | 2011 | 1474 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1526 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3586 | 0.020 |
Why?
|
Ifosfamide | 1 | 2011 | 232 | 0.020 |
Why?
|
Cauda Equina | 1 | 2010 | 45 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4336 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18358 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1484 | 0.020 |
Why?
|
Aspergillosis | 1 | 1992 | 243 | 0.020 |
Why?
|
Indoles | 1 | 2018 | 1828 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10748 | 0.020 |
Why?
|
Leukocytes | 1 | 2018 | 2025 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16886 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1547 | 0.020 |
Why?
|
Time Factors | 4 | 2010 | 39872 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2210 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1387 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2017 | 985 | 0.020 |
Why?
|
Etoposide | 1 | 2011 | 630 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3574 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2504 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 415 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2912 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 1991 | 463 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1044 | 0.020 |
Why?
|
Proteins | 1 | 2003 | 6026 | 0.020 |
Why?
|
Cost of Illness | 1 | 2018 | 1936 | 0.020 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1968 | 151 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2500 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1171 | 0.020 |
Why?
|
Behavior | 1 | 1991 | 540 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2010 | 604 | 0.020 |
Why?
|
Genotype | 1 | 2002 | 12945 | 0.020 |
Why?
|
Benzamides | 2 | 2004 | 1368 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 532 | 0.020 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 221 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2012 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5199 | 0.020 |
Why?
|
Hematologic Neoplasms | 3 | 2004 | 1890 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2011 | 509 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42062 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1927 | 0.020 |
Why?
|
Immune System | 2 | 2002 | 796 | 0.020 |
Why?
|
Quality of Life | 2 | 2019 | 13285 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2011 | 36284 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2634 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2292 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4567 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2014 | 1594 | 0.020 |
Why?
|
Optic Disk | 1 | 2010 | 421 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2038 | 0.020 |
Why?
|
Cocaine | 1 | 1991 | 958 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6068 | 0.020 |
Why?
|
Internationality | 1 | 2011 | 1000 | 0.020 |
Why?
|
Terminal Care | 1 | 2017 | 1750 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3765 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4106 | 0.020 |
Why?
|
Chromosomes, Human, Y | 1 | 2006 | 161 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7818 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4539 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2577 | 0.020 |
Why?
|
Child | 4 | 2016 | 79818 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1793 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4284 | 0.020 |
Why?
|
HIV Infections | 2 | 2011 | 17275 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3840 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1504 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2782 | 0.010 |
Why?
|
Simplexvirus | 1 | 1968 | 803 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5129 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20055 | 0.010 |
Why?
|
Cytogenetics | 1 | 2004 | 198 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2004 | 433 | 0.010 |
Why?
|
Tissue Donors | 2 | 2003 | 2311 | 0.010 |
Why?
|
Infant | 3 | 2016 | 36055 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 6293 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3339 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1992 | 2197 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11336 | 0.010 |
Why?
|
Anemia | 1 | 2012 | 1504 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9311 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4313 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3615 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3754 | 0.010 |
Why?
|
Globins | 1 | 2003 | 403 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23884 | 0.010 |
Why?
|
Bone Marrow Examination | 1 | 2002 | 154 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1533 | 0.010 |
Why?
|
Spinal Cord | 1 | 2011 | 1814 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2010 | 1171 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2003 | 293 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3262 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 717 | 0.010 |
Why?
|
Graft Survival | 2 | 2004 | 3794 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8945 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2003 | 12759 | 0.010 |
Why?
|
Cytogenetic Analysis | 1 | 2002 | 270 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2201 | 0.010 |
Why?
|
Gene Dosage | 1 | 2006 | 1218 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1060 | 0.010 |
Why?
|
Consensus | 1 | 2011 | 3099 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1992 | 2083 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2467 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11070 | 0.010 |
Why?
|
DEAD-box RNA Helicases | 1 | 2003 | 383 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12876 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5952 | 0.010 |
Why?
|
Haplotypes | 1 | 2006 | 2764 | 0.010 |
Why?
|
Erythropoiesis | 1 | 2003 | 682 | 0.010 |
Why?
|
Steroids | 1 | 2004 | 926 | 0.010 |
Why?
|
Clone Cells | 1 | 2002 | 1660 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 800 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2002 | 1351 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7980 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1593 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9574 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4217 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8175 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7502 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 73809 | 0.010 |
Why?
|
Epitopes | 1 | 2003 | 2502 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3441 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12604 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1982 | 810 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 1826 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12440 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2012 | 26183 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6895 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 1995 | 150 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 2414 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1995 | 412 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 2413 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2002 | 3156 | 0.010 |
Why?
|
Ophthalmic Solutions | 1 | 1995 | 304 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17768 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7225 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2002 | 2532 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5490 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2003 | 2621 | 0.010 |
Why?
|
DNA Primers | 1 | 1997 | 2816 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4540 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12436 | 0.010 |
Why?
|
Orbit | 1 | 1995 | 446 | 0.010 |
Why?
|
Adsorption | 2 | 1969 | 197 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1995 | 2262 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2009 | 5103 | 0.010 |
Why?
|
Carbon Isotopes | 2 | 1969 | 459 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81101 | 0.010 |
Why?
|
Ligands | 1 | 1997 | 3258 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9267 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 1995 | 931 | 0.010 |
Why?
|
Chlamydia | 1 | 1969 | 33 | 0.010 |
Why?
|
Maternal Behavior | 1 | 1991 | 307 | 0.000 |
Why?
|
Animals | 3 | 2017 | 167768 | 0.000 |
Why?
|
Centrifugation, Density Gradient | 1 | 1968 | 299 | 0.000 |
Why?
|
Thymidine | 1 | 1968 | 299 | 0.000 |
Why?
|
Motor Skills | 1 | 1991 | 519 | 0.000 |
Why?
|
Tritium | 1 | 1968 | 707 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6520 | 0.000 |
Why?
|
Culture Techniques | 1 | 1968 | 530 | 0.000 |
Why?
|
Pseudomonas aeruginosa | 1 | 1995 | 1275 | 0.000 |
Why?
|
Deoxyribonucleases | 1 | 1968 | 211 | 0.000 |
Why?
|
Leucine | 1 | 1968 | 547 | 0.000 |
Why?
|
Bile Acids and Salts | 1 | 1968 | 383 | 0.000 |
Why?
|
Cell Line | 2 | 1997 | 15591 | 0.000 |
Why?
|
Brain | 1 | 2011 | 26947 | 0.000 |
Why?
|
Heparin | 2 | 1969 | 1632 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18940 | 0.000 |
Why?
|
Rats | 1 | 1995 | 23679 | 0.000 |
Why?
|
Pregnancy | 1 | 1991 | 29742 | 0.000 |
Why?
|
Haplorhini | 1 | 1969 | 529 | 0.000 |
Why?
|
Amnion | 1 | 1969 | 197 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1969 | 2557 | 0.000 |
Why?
|
Amino Acids | 1 | 1969 | 1713 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1969 | 3824 | 0.000 |
Why?
|
Kidney | 1 | 1969 | 7016 | 0.000 |
Why?
|